Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Celgene Corporation - Contingen

TRADE

NASDAQ: CELGZHealthcare / Biotechnology / USA
1.60+0.04+2.56%Vol 9 3271Y Perf 5.61%
Sep 25th, 2018 16:00
BID1.57 ASK1.60
Open1.57 Previous Close1.56
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★★★     67.39
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)- 
Earnings Rating
Price Range Ratio 52wk %
58.66 
Earnings Date

Today's Price Range

1.571.60

 

52wk Range

0.112.65

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
5.26%
3 Months
310.26%
6 Months
384.85%
1 Year
5.61%
3 Years
-2.42%
5 Years
46.67%

Quotes

Name / TickerPriceChg.Chg.%
CELGZ1.600.04002.56
AAPL222.191.40000.63
GOOG1 184.6511.28000.96
MSFT114.45-0.2200-0.19
XOM86.50-0.1000-0.12
WFC54.23-0.0300-0.06
JNJ138.64-1.8300-1.30
FB164.91-0.5000-0.30
GE11.27-0.4700-4.00
JPM116.39-0.3300-0.28
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.20
Current Ratio 1.50
Long Term Debt to Total Capital 0.85
Total Debt to Equity 6.20
Interest Coverage 8.10
Leverage Ratio 5.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin96.50
EBIT Margin36.00
EBITDA Margin39.70
Pre-tax Profit Margin26.40
Profit Margin19.45
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio -
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -
Cash Flow Per Share -
Price to Tangible Book-
Book Value per Share-
Enterprise Value (in ths.)-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)32.54
ROE last 12 Months 46.38
Return on Assets (5Y Avg) 6.19
ROA last 12 Months 8.68
Return on Capital (5Y Avg) 14.26
ROC last 12 Months 13.09
Return on invested Capital Q 4.62
Return on invested Capital Y14.95
Assets Turnover0.40
Receivables Turnover7.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)14 101 000
Revenue per Share -
Revenue Growth 3 Years 15.70
Revenue Growth 5 Years 17.97
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume9 327
Shares Outstanding (in ths.)0
Trades Count14
Dollar Volume14 417
Avg. Volume36 415
Avg. Weekly Volume9 665
Avg. Monthly Volume36 521
Avg. Quarterly Volume62 304

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

77%23%

Bearish Bullish

48%52%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

x